Evidence map›Paper›PMID 21080231›Full record

ArticleMolecular imaging and biology2011

Impact of indium-111 oxine labelling on viability of human mesenchymal stem cells in vitro, and 3D cell-tracking using SPECT/CT in vivo.

Franz Josef Gildehaus, Florian Haasters, Inga Drosse, Erika Wagner, Christian Zach, Wolf Mutschler, Paul Cumming, Peter Bartenstein, Matthias Schieker

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular imaging and biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Stem cells therapy molecular tracking - the special focus on nuclear medicine.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2026
    Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Direct Cell Radiolabeling forChemical reviews · 2022
    Review
  9. Article
  10. Review
  11. Article
  12. NoninvasiveWorld journal of stem cells · 2020
    Review
  13. Article
  14. Article
  15. Article
  16. Clinical cancer research : an official journal of the American Association for Cancer Research · 2020
    Article
  17. Relevance of immune cell and tumor microenvironment imaging in the new era of immunotherapy.Journal of experimental & clinical cancer research : CR · 2020
    Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Franz Josef GildehausDepartment of Nuclear Medicine, University of Munich (LMU), Munich, Germany. franz.gildehaus@med.uni-muenchen.de
Florian Haasters
Inga Drosse
Erika Wagner
Christian Zach
Wolf Mutschler
Paul Cumming
Peter Bartenstein
Matthias Schieker

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study investigates the effects of (111)In-oxine incorporation on human mesenchymal stem cells' (hMSC) biology and viability, and the applicability of (111)In-oxine for single-photon emission computed tomography/X-ray computed tomography (SPECT/CT) monitoring of hMSC in vivo. PROCEDURES: HMSC were labelled with 10 Bq/cell. Cellular retention of radioactivity, cell survival, and migration were evaluated over 48 h. Metabolic activity was assessed over 14 days and the hMSC's stem cell character was evaluated. Serial SPECT/CT was performed after intra-osseous injection to athymic rats over 48 h.

resultsLabelling efficiency was 25%, with 61% of incorporated (111)In remaining in the hMSC at 48 h. The radiolabelling was without effect on cell viability, stem cell character, and plasticity, whereas metabolic activity and migration were significantly reduced. Grafted cells could be imaged in situ with SPECT/CT.

conclusions(111)In-oxine labelling moderately impaired hMSC's functional integrity while preserving their stem cell character. Combined SPECT/CT imaging of (111)In-oxine-labelled hMSC opens the possibility for non-invasive sequential monitoring of therapeutic stem cells.

Indexed as

Staining and LabelingTomography, Emission-Computed, Single-PhotonTomography, X-Ray ComputedAnimalsCell DifferentiationCell LineCell MovementCell SurvivalCell TrackingFemaleHumansImmunohistochemistryMesenchymal Stem CellsOrganometallic CompoundsOxyquinolineRats, Nudeindium oxineOrganometallic CompoundsOxyquinoline

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.